生命科学与医药
Search documents
万润股份:公司是以研发创新驱动的平台型企业
Zheng Quan Ri Bao· 2025-11-21 10:19
证券日报网讯万润股份11月21日在互动平台回答投资者提问时表示,公司是以研发创新驱动的平台型企 业,现主要从事电子信息材料产业、环保材料产业、新能源材料产业以及生命科学与医药产业四个领域 产品的研发、生产和销售,拥有超过10,000种化合物的生产技术,其中超过4,000种产品已投入市 场。 (文章来源:证券日报) ...
万润股份10月20日获融资买入1641.33万元,融资余额4.10亿元
Xin Lang Cai Jing· 2025-10-21 01:29
Core Insights - Wanrun Co., Ltd. experienced a stock price increase of 0.96% on October 20, with a trading volume of 176 million yuan [1] - The company reported a financing buy-in of 16.41 million yuan and a financing repayment of 28.11 million yuan on the same day, resulting in a net financing outflow of 11.70 million yuan [1] - As of October 20, the total margin balance for Wanrun Co., Ltd. was 410 million yuan, which is 3.53% of its circulating market value, indicating a low financing balance compared to the past year [1] Financing and Margin Data - On October 20, the financing buy-in was 16.41 million yuan, while the current financing balance stands at 410 million yuan, which is below the 50th percentile level over the past year [1] - In terms of short selling, 300 shares were repaid and 1,500 shares were sold short on October 20, with a total short selling amount of 18,800 yuan [1] - The short selling balance is 7,000 shares, with a total value of 87,900 yuan, also indicating a low level compared to the past year [1] Company Overview - Wanrun Co., Ltd. is located in Yantai, Shandong Province, and was established on July 5, 1995, with its listing date on December 20, 2011 [1] - The company operates in three main business areas: electronic information materials, environmental protection materials, and health products, with revenue contributions of 78.58%, 20.09%, and 1.33% respectively [1] Financial Performance - As of June 30, the number of shareholders for Wanrun Co., Ltd. was 48,600, a decrease of 6.13% from the previous period, while the average circulating shares per person increased by 6.53% to 18,710 shares [2] - For the first half of 2025, the company reported a revenue of 1.87 billion yuan, a year-on-year decrease of 4.42%, while the net profit attributable to shareholders was 218 million yuan, reflecting a year-on-year increase of 1.35% [2] Dividend Distribution - Since its A-share listing, Wanrun Co., Ltd. has distributed a total of 2.005 billion yuan in dividends, with 646 million yuan distributed over the past three years [3] Institutional Holdings - As of June 30, 2025, Hong Kong Central Clearing Limited was the ninth largest circulating shareholder, holding 8.5757 million shares, an increase of 2.0926 million shares from the previous period [3]
万润股份股价涨5.11%,银河基金旗下1只基金重仓,持有5.37万股浮盈赚取3.6万元
Xin Lang Cai Jing· 2025-09-24 06:28
Group 1 - The core viewpoint of the news is that Wanrun Co., Ltd. has seen a significant increase in its stock price, with a rise of 5.11% to 13.79 CNY per share, and a total market capitalization of 12.728 billion CNY [1] - Wanrun Co., Ltd. is engaged in three main business areas: electronic information materials, environmental protection materials, and health industry products, with functional materials accounting for 78.58% of revenue, life sciences and pharmaceuticals for 20.09%, and other categories for 1.33% [1] Group 2 - From the perspective of fund holdings, one fund under Galaxy Fund has a significant position in Wanrun Co., Ltd., specifically the Galaxy New Materials Stock Initiation A (020276), which reduced its holdings by 5,800 shares in the second quarter, maintaining 53,700 shares, representing 5.26% of the fund's net value [2] - The Galaxy New Materials Stock Initiation A (020276) has achieved a year-to-date return of 32.29%, ranking 1479 out of 4220 in its category, and a one-year return of 62.93%, ranking 1436 out of 3814 [2] - The fund manager of Galaxy New Materials Stock Initiation A is Jin Ye, who has been in the position for approximately 3 years and 265 days, with the fund's total asset size at 54.3398 million CNY [3]